title: Decitabine in patients with relapsed acute myeloid leukemia (AML) after allogeneic stem cell transplantation (allo-SCT).
authors.forename: Siddhartha
authors.initials: S
authors.lastname: Ganguly
authors.forename: Manik
authors.initials: M
authors.lastname: Amin
authors.forename: Clint
authors.initials: C
authors.lastname: Divine
authors.forename: Omar S
authors.initials: OS
authors.lastname: Aljitawi
authors.forename: Sunil
authors.initials: S
authors.lastname: Abhyankar
authors.forename: Joseph P
authors.initials: JP
authors.lastname: McGuirk
mesh_terms: D000328:Adult; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D001374:Azacitidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D015331:Cohort Studies; D000077209:Decitabine; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012189:Retrospective Studies; D014184:Transplantation, Homologous; D055815:Young Adult
chemical_list: D000964:Antimetabolites, Antineoplastic; D000077209:Decitabine; D001374:Azacitidine